Care Transitions for Complex Patient - Cycle 1 and Cycle 2

NCT01039324 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8422

Last updated 2014-05-15

No results posted yet for this study

Summary

The purpose of this study is to improve patient care and safety while decreasing ED visit rates by sending specific information about care transitions related to hospital admission and discharge and emergency department and specialty care visits to primary care practices, care managers and patients with the use of health information technology (HIT) shared across a community-based network of providers.

Cycle 1 focuses on the impact of notices about ED encounters and hospitalizations derived from billing data that are sent to care managers for all 47,000 patients in the Northern Piedmont Community Care Network (NPCCN). Cycle 2 explores the impact of letters sent to patients, and care event reports sent to a patient's medical home in addition to notices sent to care managers about ED encounters, hospitalization and specialty care based on ADT (Admission Discharge Transfer) and billing data on 4,600 patients with complex health needs.

Conditions

Interventions

OTHER

Reports

Primary care event reports and patient letters

OTHER

Reports and Notices

Primary care event reports, patient letters and care manager notices

OTHER

Usual care

This is the study's control group

Sponsors & Collaborators

  • Northern Piedmont Carolina Community Care Partners

    collaborator UNKNOWN
  • North Carolina Division of Medical Assistance

    collaborator UNKNOWN
  • Duke University

    lead OTHER

Principal Investigators

  • Eric Eisenstein, DBA · Duke University

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2012-03-31
Completion
2012-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01039324 on ClinicalTrials.gov